Skip to main content

Software

Genomics Payment Manager

Support accurate claim submission and reimbursement for genetic testing with our cutting-edge solution.

Proactively manage genetic test spend

As genetic testing becomes the standard of care for many health conditions, the number of tests available in the market has soared. With over 10 new tests added daily, many don’t meet the criteria for clinical or analytical utility. And with fewer than 500 CPT® billing codes to describe the nearly 130,000 genetic tests available in the market, reimbursement can be complex. 1,2

Optum® Genomics Payment Manager helps health plans proactively manage genetic testing spend by correctly identifying tests, automatically mapping billing codes to genetic tests and analyzing claims for inappropriate billing behaviors.

Unique test identification

Through our exclusive partnership with Palmetto GBA, who administers the MolDX program leveraged by Medicare Fee-For-Service (FFS), we utilize the reliable DEX® Diagnostics Exchange. This platform assigns unique DEX Z-Code® identifiers to each test, aiding in the cataloging and management of the tests. By leveraging these familiar processes, we help validate that only clinically relevant and appropriate tests are covered, aligning with health plan policies.

Z-Codes drill down beyond the CPT® code and identify a discrete genetic test on a claim, allowing for automated correct coding edits, Medicare-sourced coverage determinations and pricing recommendations.

Improve regulatory compliance

DEX Z-Codes® are an extension of the Medicare FFS MOlDx program, which has been used for over a decade by Medicare Administrative Contractors (MACs) to improve payment accuracy on genetic testing claims.

Biomarker compliance laws vary by state. Some states require health plans to cover biomarker testing similar to Medicare Fee-For-Service (FFS). Genomics Payment Manager can help health plans improve patient access to necessary tests.

Key benefits

Support biomarker compliance and accurate reimbursement for genetic testing.  

Greater policy enforcement and payment specificity

We create a one-to-one relationship between the Z-code, CPT code, test and lab, allowing for automated policy enforcement and payment decisions at the discrete test level.

Commitment to test quality

The DEX® Diagnostics Exchange performs clinically stringent technical assessments on all lab-submitted tests to help validate quality for members and physicians.

Related healthcare insights

View all

Video

Advancing dme benefits management

Learn how DME Navigator can help streamline durable medical equipment (DME) benefits management. 

On-demand webinar

Value dex z codes

Optum and Palmetto experts partner in discussing how to solve genetic lab challenges in legacy solutions.

On-demand webinar

Innovative approaches to collaborate with PCPs

Understanding the challenges confronting Medicare Advantage plans and their Medical Loss Ratio.

Get accurate reimbursement for genetic testing with Optum Genomics Payment Manager

Complementary solutions

DME Navigator

Our integrated durable medical equipment (DME) solution helps health plans manage spend while improving the experience for members, DME suppliers and the ordering providers

Ancillary Benefits Management

Reduce the burden of managing ancillary benefits programs separately across the care continuum. Our solutions leverage an affordability framework to close gaps for better care with lower costs.

Sources

1. Halbisen AL, Lu CY. Trends in Availability of Genetic Tests in the United States, 2012-2022. J Pers Med. 2023 Apr 6;13(4):638. doi: 10.3390/jpm13040638. PMID: 37109024; PMCID: PMC10142561. 

2. Laboratory Hub. Laboratory Hub. Understanding CPT and ICD Codes in Laboratory Billing. Oct. 7, 2023.